APA (7th ed.) Citation

MN, V., JA, N., C, M., A, K., HX, T., K, S., . . . AK, W. (2026). Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza. Molecular therapy. Nucleic acids, 37(2), 102873. https://doi.org/10.1016/j.omtn.2026.102873

Chicago Style (17th ed.) Citation

MN, Vu, Neil JA, Mackenzie-Kludas C, Kelly A, Tan HX, Subbarao K, Lee WS, and Wheatley AK. "Delivery of Monoclonal Antibodies Using MRNA Lipid Nanoparticles Confers Protection Against SARS-CoV-2 and Influenza." Molecular Therapy. Nucleic Acids 37, no. 2 (2026): 102873. https://doi.org/10.1016/j.omtn.2026.102873.

MLA (9th ed.) Citation

MN, Vu, et al. "Delivery of Monoclonal Antibodies Using MRNA Lipid Nanoparticles Confers Protection Against SARS-CoV-2 and Influenza." Molecular Therapy. Nucleic Acids, vol. 37, no. 2, 2026, p. 102873, https://doi.org/10.1016/j.omtn.2026.102873.